Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors

• Kenny has proven track record of driving growth at companies within the healthcare space and holds significant management and public company board experience, most recently as CEO of Meridian Bioscience
  
• As CEO Kenny managed the sale of Meridian Biosciences in an all-cash transaction valued at approximately $1.53 billion
  

NEWPORT BEACH, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment of Jack Kenny, former CEO and board member of Meridian Bioscience, Inc., to its Board of Directors. Meridian Biosciences (formerly traded on Nasdaq under VIVO) is a leading global provider of diagnostic testing solutions. Meridian Biosciences was acquired on January 31, 2023 by SD Biosensor, Inc. and SJL Partners LLC in an all-cash transaction valued at approximately $1.53 billion.

"I'm excited to join Biomerica's Board and contribute to the launch and growth of the company’s groundbreaking product, inFoods IBS. This product holds the potential to not only significantly improve the lives of millions of individuals dealing with IBS but also capture the interest of larger multinational diagnostic companies. The technology's appeal extends beyond its ability to enhance patient well-being, as it also stands to reduce healthcare costs and equip physicians with a precise, personalized approach to treating IBS.

"The compelling clinical study data supporting inFoods IBS has underscored its potential to deliver therapeutic benefits for IBS patients. As I take on my role within Biomerica's board, I'm eagerly looking forward to close collaboration with the management team. Together, we'll strive to introduce this remarkable technology to medical professionals and patients around the world with the goal of improving healthcare outcomes while driving down costs for patients and insurers," said Mr. Kenny.

“Jack brings a wealth of commercial experience and relationships in the medical diagnostic industry. His industry insights will be invaluable as we launch inFoods IBS both domestically and internationally,” said Zack Irani, CEO of Biomerica. “Jack brings more than 30 years of experience as a senior executive at large public companies in the healthcare, clinical laboratory and medical device industries. Most recently, his leadership as CEO drove outstanding growth at Meridian Bioscience. Jack also brings strong public company governance experience that will facilitate corporate oversite as our business expands and grows.”